724 results on '"Kumar, Alan Prem"'
Search Results
52. Mechanism of epithelial‐mesenchymal transition in cancer and its regulation by natural compounds
53. Biomimetic nanotherapeutics for targeted drug delivery to glioblastoma multiforme
54. The potential role of boswellic acids in cancer prevention and treatment
55. c-Met activation leads to the establishment of a TGFβ-receptor regulatory network in bladder cancer progression
56. Macrophage IL-1β contributes to tumorigenesis through paracrine AIM2 inflammasome activation in the tumor microenvironment.
57. Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer
58. Cucurbitacins as Potent Chemo-Preventive Agents: Mechanistic Insight and Recent Trends
59. Dendrimers as nanoscale vectors: Unlocking the bars of cancer therapy
60. Cardamonin represses proliferation, invasion, and causes apoptosis through the modulation of signal transducer and activator of transcription 3 pathway in prostate cancer
61. Demystifying the Functional Role of Nuclear Receptors in Esophageal Cancer
62. Chitosan‐based nanoscale systems for doxorubicin delivery: Exploring biomedical application in cancer therapy
63. Long noncoding RNAs (lncRNAs) in pancreatic cancer progression
64. Oleanolic acid and its synthetic derivatives for the prevention and therapy of cancer: Preclinical and clinical evidence
65. Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors
66. Secreted frizzled related proteins: Implications in cancers
67. Modulation of diverse oncogenic transcription factors by thymoquinone, an essential oil compound isolated from the seeds of Nigella sativa Linn
68. Molecular Targets of Ascochlorin and Its Derivatives for Cancer Therapy
69. Chapter 4 Triterpenoids and Sesquiterpenoids for Prostate Cancer Therapy
70. SIRIUS, Ultra-Scintillating Upconversion Breast Implant for Remote Orthotopic Photodynamic Therapy.
71. Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer
72. 2,3,5,6-Tetramethylpyrazine Targets Epithelial-Mesenchymal Transition by Abrogating Manganese Superoxide Dismutase Expression and TGFβ-Driven Signaling Cascades in Colon Cancer Cells
73. (Nano)platforms in bladder cancer therapy: Challenges and opportunities
74. Targeting Nuclear Receptors in Lung Cancer—Novel Therapeutic Prospects
75. Doxorubicin-loaded graphene oxide nanocomposites in cancer medicine: stimuli-responsive carriers, co-delivery and suppressing resistance
76. Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma
77. Exosomes as Promising Nanostructures in Diabetes Mellitus: From Insulin Sensitivity to Ameliorating Diabetic Complications
78. (Nano)platforms in bladder cancer therapy: Challenges and opportunities.
79. Cucurbitacins as Potent Chemo-Preventive Agents: Mechanistic Insight and Recent Trends.
80. NF-κB in cancer therapy
81. PI3K/AKT Signaling Tips the Balance of Cytoskeletal Forces for Cancer Progression
82. Ionic Liquid-Assisted Fabrication of Bioactive Heterogeneous Magnetic Nanocatalyst with Antioxidant and Antibacterial Activities for the Synthesis of Polyhydroquinoline Derivatives
83. Gene regulation by antisense transcription: A focus on neurological and cancer diseases
84. Identification of novel peroxisome proliferator-activated receptor-gamma (PPARγ) agonists using molecular modeling method
85. Pre-Clinical and Clinical Applications of Small Interfering RNAs (siRNA) and Co-Delivery Systems for Pancreatic Cancer Therapy
86. Gallic acid for cancer therapy: Molecular mechanisms and boosting efficacy by nanoscopical delivery
87. Tris(dibenzylideneacetone)dipalladium(0) (Tris DBA) Abrogates Tumor Progression in Hepatocellular Carcinoma and Multiple Myeloma Preclinical Models by Regulating the STAT3 Signaling Pathway
88. Editing SOX Genes by CRISPR-Cas: Current Insights and Future Perspectives
89. DEAD-box helicase DP103 defines metastatic potential of human breast cancers
90. Effects of Migrating Cell-Induced Matrix Reorganization on 3D Cancer Cell Migration
91. Simvastatin sensitizes human gastric cancer xenograft in nude mice to capecitabine by suppressing nuclear factor-kappa B-regulated gene products
92. Suppression of essential pro-inflammatory signaling pathways by natural agents for the therapy of Multiple Myeloma
93. Targeting transcription factor STAT3 for cancer prevention and therapy
94. Abrogation of STAT3 signaling cascade by zerumbone inhibits proliferation and induces apoptosis in renal cell carcinoma xenograft mouse model
95. Mindfulness Awareness Practice (MAP) to Prevent Dementia in Older Adults with Mild Cognitive Impairment: Protocol of a Randomized Controlled Trial and Implementation Outcomes
96. Crocetin imparts antiproliferative activity via inhibiting STAT3 signaling in hepatocellular carcinoma
97. Mast cells: Therapeutic targets for COVID ‐19 and beyond
98. In response to “Comment on “Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis?” Cancer Lett. 2021 May 2; 509 (2021) 63–80”
99. Diosgenin attenuates tumor growth and metastasis in transgenic prostate cancer mouse model by negatively regulating both NF-κB/STAT3 signaling cascades
100. The multidimensional role of the Wnt/β‐catenin signaling pathway in human malignancies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.